Clinical Evidence for Utilizing Cannabinoids in the Elderly

Isr Med Assoc J. 2017 Feb;19(2):71-75.

Authors

Itay Katz^{1

2}, Daphna Katz^{1

2}, Yehuda Shoenfeld^{1

3}, Bat Sheva Porat-Katz⁴

Affiliations

¹ Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
² Hadassah-Hebrew University Medical School, Jerusalem, Israel.
³ Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁴ Smith Faculty of Agriculture, Food and Environment School of Nutritional Sciences, The Hebrew University of Jerusalem, Rehovot, Israel.

PMID: 28457053

No abstract available

MeSH terms

Aged
Cannabinoid Receptor Agonists / pharmacology
Cannabinoids / pharmacology*
Cognition / drug effects*
Dementia / drug therapy
Dementia / metabolism
Dementia / psychology
Dyssomnias / drug therapy*
Dyssomnias / metabolism
Endocannabinoids / metabolism
Geriatrics / methods
Humans
Parkinson Disease / drug therapy*
Parkinson Disease / metabolism
Parkinson Disease / physiopathology
Psychomotor Performance / drug effects*
Treatment Outcome

Substances

Cannabinoid Receptor Agonists
Cannabinoids
Endocannabinoids